You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TBPH Disposition Disclosure
Mitchell Dean J · SEC Form 4 · Filed Sep 24, 2026
Disposition
Reported value range
Not reported
Mitchell Dean J Director
TBPH
Theravance Biopharma
TBPH
Transaction date
Sep 23, 2026
Public filing date
Sep 24, 2026
Filing lag
Filed 1 day later
TBPH daily price context
Close on/before transaction
$17.03
Sep 23, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Share Option (Right to Buy) on Ordinary Shares
- Quantity / price
- 6,000 shares
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001199297-26-000006
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH Current | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |